Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study.

Conclusion: PEGylated rhGH replacement therapy is effective and safe in pediatric patients with GHD. The adherence to once-weekly PEGylated rhGH therapy is superior to daily rhGH in children with GHD. PMID: 31641350 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31641350?dopt=Abstract

Source: International Journal of Endocrinology - October 25, 2019 Category: Endocrinology Tags: Int J Endocrinol Source Type: research